News
Limnopharma awarded with a Research Project from the NEOTEC program (CDTI; Spanish Ministry of Science and Innovation)
Limnopharma is awarded with a Research Project funded by the NEOTEC program (CDTI; Spanish Ministry of Science and Innovation), for new Business Projects from innovative Start-up companies. The project granted includes a series of experiments for the preclinical...
read moreLimnopharma signs a research agreement with “Fundación Progreso y Salud” for the execution of the “Lead Retina” research project
Limnopharma signs a Research Agreement with “Fundación Progreso y Salud”, an organization which belongs to the Andalusian Region Ministry of Health (Spain). The agreement includes the execution of the “Lead retina” research project, led by Dr. Dr. Díaz-Corrales, to...
read moreNew SAB members
In August 2020, Dr. Diego del Río Días-Jara and Dr. Claudio Punzo join Limnopharma’s Scientific Advisory Board. Diego del Río holds a PhD. In Chemistry and is an expert in business development and market analyses. Claudio Punzo is Associate Professor at the University...
read moreLimnopharma’s new CEO
On August 1st, 2020, Limno hires Dr. Elena Puerta-Fernández as company’s CEO. Elena holds a Pharmacy degree and PhD. in Biochemistry and Molecular Biology by the University of Granada. She has a research career longer than 20 years, with wide international experience....
read moreLimno participates in “Misión Directa a Boston
Limno was selected to participate in the program “Misión Directa a Boston”, a program funded by Extenda- Agencia Andaluza de Promoción Exterior, from the Andalusian Government to promote the internalization of Andalusian start-up companies. Boston is one of the more...
read moreLimno’s presentation at I Life Science Investor Capital Forum (February, 6th 2020)
Limnopharma was selected as one of the 10 companies presenting at the I Life Science Investor Capital Forum. The event, held in the Parc Científic (Barcelona), was sponsored by Foro Capital Pymes, Canaan R&I, Keiretsu Forum and Parc Científic de Barcelona. During...
read moreLimnopharma receives an international award for the best European start-up
Limnopharma has received the Avenir Matmut award for the best European start-up at the EIT Health Summit event in Paris on December 2. This award has been awarded by La Fondation de l’Avenir, which aims to support and promote research and innovation in health....
read moreLimno’s presentation at the EIT Health Summit 2019
Limno's presentation at the EIT Health Summit 2019. Here is the link: https://summit.eithealth.eu/
read moreLimno’s presentation at MedInBio (Nov 26, 2019)
Limno's presentation at MedInBio. Here is the link to the programme: https://medinbio.es/programa-2019/
read more
New therapies for retinal diseases.
Treatments for Age-Related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)
Headquarters
Avda. de la Innovación, 1
Edificio BIC
18016 - Granada